Argobio Studio

Biotechnology
StartupNo open roles listed
Data updated Nov 22, 2026Full reportReport a mistake

Facts

as of Nov 22, 2026

Argobio SAS is a newly-created START-UP STUDIO dedicated to novel Therapeutics aiming to nurture and launch at least five breakthrough Biotech companies over the next five years.Argobio will source innovative early-stage projects from renowned European academic research institutions.

Employees
11-50estimated range
Official records
LEI 89450027R2WGTFUBV051
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Milestones

Jun 17, 2025
Increased its share capital $52.9M · BODACC
Aug 30, 2024
Increased its share capital $42.6M · BODACC
May 7, 2023
Increased its share capital $32.4M · BODACC
Jun 12, 2022
Increased its share capital $21.6M · BODACC
Mar 24, 2021
Increased its share capital $10.8M · BODACC
Mar 2021
Each milestone is dated by its source: registers, filings, the press